KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $139.0 million.

  • Bristol Myers Squibb's Share-based Compensation rose 775.19% to $139.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $540.0 million, marking a year-over-year increase of 505.84%. This contributed to the annual value of $507.0 million for FY2024, which is 212.36% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Share-based Compensation of $139.0 million as of Q3 2025, which was up 775.19% from $137.0 million recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Share-based Compensation peaked at $157.0 million during Q2 2021, and registered a low of $107.0 million during Q1 2022.
  • For the 5-year period, Bristol Myers Squibb's Share-based Compensation averaged around $130.8 million, with its median value being $132.0 million (2023).
  • As far as peak fluctuations go, Bristol Myers Squibb's Share-based Compensation plummeted by 2913.91% in 2022, and later soared by 1810.34% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Share-based Compensation stood at $133.0 million in 2021, then fell by 10.53% to $119.0 million in 2022, then grew by 6.72% to $127.0 million in 2023, then decreased by 5.51% to $120.0 million in 2024, then increased by 15.83% to $139.0 million in 2025.
  • Its Share-based Compensation stands at $139.0 million for Q3 2025, versus $137.0 million for Q2 2025 and $144.0 million for Q1 2025.